Performance of the ATRIA Bleeding Score in Predicting the Risk of In-Hospital Bleeding in Patients with ST-Elevation
Fethi Yavuz1, Mehmet Kaplan2, Abdullah Yildirim3
1Department of Cardiology, Adıyaman University Training and Research Hospital, Adıyaman, Turkey.
Brazilian Journal of Cardiovascular Surgery
|June 8, 2022
Summary
The ATRIA bleeding score effectively predicts major bleeding in myocardial infarction (MI) patients undergoing percutaneous coronary intervention (PCI). This score is also valuable for ST-segment elevation MI (STEMI) and non-STEMI (NSTEMI) subgroups.
Area of Science:
- Cardiology
- Clinical Risk Stratification
- Hemorrhagic Complications
Background:
- Assessing bleeding risk in myocardial infarction (MI) patients is vital for prognosis.
- The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) score is validated for atrial fibrillation (AF) bleeding risk.
- The predictive value of the ATRIA score for bleeding post-percutaneous coronary intervention (PCI) in MI patients is unknown.
Purpose of the Study:
- To evaluate the predictive performance of the ATRIA bleeding score.
- To compare ATRIA with CRUSADE and ACUITY-HORIZONS bleeding scores.
- To assess predictive value in ST-segment elevation MI (STEMI) and non-STEMI (NSTEMI) patients.
Main Methods:
- Retrospective evaluation of 830 consecutive STEMI and NSTEMI patients undergoing PCI.
- Calculation of ATRIA, CRUSADE, and ACUITY-HORIZONS bleeding scores.
- Assessment of model discrimination using C-statistics.
Main Results:
- Major bleeding occurred in 6.3% of patients.
- All three bleeding scores (ATRIA, CRUSADE, ACUITY-HORIZONS) showed significant predictive value.
- Discriminatory abilities were similar: C-statistics 0.810 (ATRIA), 0.832 (CRUSADE), and 0.909 (ACUITY-HORIZONS).
- Predictive value was consistent across STEMI and NSTEMI subgroups.
Conclusions:
- The ATRIA bleeding score is a useful tool for predicting major in-hospital bleeding in MI patients.
- The ATRIA score maintains good predictive value in STEMI and NSTEMI subgroups.
- This study supports the utility of the ATRIA score beyond its original indication in AF patients.
Keywords:
AnticoagulantsAtrial FibrilationBleedingMyocardial InfarctionRisk AssessmentRisk FactorsSR Elevation Myocardial InfarctationMore Related Videos
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
85
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
85
01:30Acute Coronary Syndrome III: Diagnostic Studies
27
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
27
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
55
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
55
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
357
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
357
01:28Acute Coronary Syndrome IV: Interprofessional Care
34
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
34
01:30Dysrhythmias V: Evaluating Dysrhythmias
123
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
123